A recent University of Iowa Health Care study calls into question the reliability of a classification system used to evaluate treatment outcomes in children with Legg-Calve-Perthes Disease. The Stulberg Classification System, developed in 1981, predicts long-term patient outcomes but has poor reliability among surgeons.
Researchers developed a transgenic mouse model of chronic liver disease caused by hepatitis B virus (HBV), enabling the study of immune responses and drug development. The model opens opportunities for scientists to test drugs in the liver and understand how HBV causes liver disease.
A 5-year clinical trial led by Thomas Jefferson University aims to investigate the effects of GM1 ganglioside on improving Parkinson's disease symptoms, delaying disease progression, and restoring damaged brain cells. The study will compare the drug to standard treatments, using advanced imaging techniques to visualize dopamine termina...
Researchers created genetically engineered mice with pathological characteristics of Alzheimer's disease, providing a new model for studying the disease. The mice exhibit amyloid deposits similar to those found in human patients, and further elevation of beta-amyloid accelerates the age of onset of pathological changes.
Researchers developed a method to identify high-risk individuals with Parkinson's disease using SPECT brain imaging and beta CIT radiopharmaceutical. They differentiated between Parkinson's patients and controls, as well as relatives of Parkinson's patients, with reduced drug binding.
A new study by researchers from the University of Washington reveals that depression significantly impairs heart disease patients' ability to work and perform daily activities. Patients with both major and minor depression were found to function less well than nondepressed patients, reporting more heart disease symptoms.
A recent study by Brown University researchers has found a link between agrin protein and Alzheimer's disease plaques. The protein, involved in nervous system development, may play a role in the disease's progression.
Researchers found that Thalomid significantly improved symptoms for two-thirds of patients with chronic, steroid-dependent or unresponsive Crohn's disease. Common side effects included drowsiness and peripheral neuropathy. The study suggests a Phase III trial using Thalomid to treat Crohn's disease should be conducted.
Northwestern University researchers have identified key peptides that can halt and even reverse kidney disease in lupus. The peptides were found to be effective in delaying the onset of severe kidney disease in young mice and prolonging survival in adult mice with established kidney disease.
A University of Pittsburgh team used electron beam computed tomography and carotid ultrasounds to assess heart disease in living people. They found that pre-menopausal risk factors such as smoking and low-density cholesterol strongly predict the development of coronary artery disease after menopause.
Researchers found a direct dose-response relationship between alcohol consumption and gum disease severity. Low antioxidant vitamins like selenium increased the risk of gum disease by 13-fold.
Researchers have identified two genetic mutations as the cause of megaloblastic anemia 1, a rare disease affecting vitamin B-12 absorption. The disease is exceedingly rare, occurring in only one person in a million, but can be fatal if left untreated.
People with diabetes are at increased risk of getting periodontal disease, which can lead to problems with blood sugar control and complications like vision problems and cardiovascular disease. Clinical studies show that people with severe periodontal disease are six times more likely to have poor glycemic control.
Three university hospitals will receive funding to advance understanding of Parkinson's disease and develop new treatments. Investigators will study the cause of the disease, diagnose and treat it, and provide training for young scientists.
Free-radical activity was found to be roughly doubled in the frontal and temporal lobes of brains of people who died of Alzheimer's disease. The levels of two biochemical markers of free-radical tissue damage were also elevated in these areas, which are critical for memory and intellectual function.
Researchers have created a transgenic mouse model of Huntington's disease, exhibiting progressive behavioral and motor dysfunction. The mice developed similar neuropathological changes to those seen in human Huntington's disease, with symptoms worsening as the abnormal gene load increased.
Researchers have confirmed a genetic influence for Alzheimer's disease in families with high incidence of the disorder. The study identified a gene on chromosome 12 associated with an increased risk and susceptibility to late-onset Alzheimer's disease, offering new insights into the disease's causes.
The HERS study found that hormone replacement therapy (HRT) increased risk of non-fatal heart attacks and death in postmenopausal women with established heart disease. In the three-year follow-up, more deaths from heart disease occurred in the HRT group than in the untreated group.
A University of Rochester team has developed a technology that provides the most thorough information yet on cells from the brains of deceased Alzheimer's patients, enabling comparison with healthy and sick cells. The study identified five genes whose expression differed significantly between healthy and Alzheimer's brains.
Researchers at University of Chicago and Johns Hopkins Medical Institutions identify genetic regions on chromosomes 1p, 3q, and 4q that appear to contain genes triggering the onset of inflammatory bowel disease. The study confirms the role of previously localized gene IBD1 in concert with another disease gene on chromosome 1.
A new study from Penn State found that families with patients in the early stages of Alzheimer's disease are more likely to accept available treatment, whereas those with advanced-stage patients may choose to withhold care. The study also highlighted the need for family involvement in making treatment decisions.
Researchers found that African Americans and Hispanics with the APOE-4 allele have a similar risk of Alzheimer's disease as whites, but those without the allele had significantly increased risks. The study suggests that there may be new genes or environmental factors involved in the disease.
Researchers have identified a new tick-borne disease in North Carolina and the Southeast that is distinct from Lyme disease. The disease, caused by an unknown organism, produces symptoms similar to ehrlichiosis but without a telltale rash. Investigation led by Dr. Kathryn Kirkland suggests the infection can be cured with antibiotics.
Researchers found increased levels of butyrylcholinesterase (BChE) in brains with compact and insoluble beta-amyloid plaques, a hallmark of Alzheimer's disease. BChE may play a role in transforming benign amyloid protein deposits into the disease-causing plaques.
Researchers have identified a genetic risk factor for late-onset Alzheimer's disease, combining the E4 variant of apolipoprotein E with the butyrylcholinesterase K variant. This combination significantly increases the risk of developing Alzheimer's disease in people over 65 years old.
Researchers at Duke University have developed a genetically engineered enzyme treatment to address Pompe disease, a condition causing skeletal, heart, and lung muscle destruction. The new therapy will be tested in infants with the most severe symptoms first.
Researchers at Oregon Health & Science University found an association between the HLA-A2 gene and the age of onset for Alzheimer's disease. The study suggests that the two susceptibility genes HLA-A2 and apolipoprotein E (APOE) together account for a decade variation in the age of onset.
Scientists at the NIH have identified a gene abnormality causing some cases of Parkinson's disease, which affects nerve cells and dopamine production. The discovery provides a new tool for understanding cellular abnormalities in Parkinson's disease and connects it to research on Alzheimer's disease.
Researchers found a significant delay in disease progression with selegiline and Vitamin E treatment, particularly among those with moderately severe disease. The drugs showed promise in reducing symptoms, but further studies are needed to confirm their effectiveness.
A transgenic mouse model of Huntington's disease has been developed, exhibiting symptoms resembling chorea and epileptic seizures. The R-6 strain is the first known mouse model to display these characteristics, allowing researchers to study the disease's progression.
Researchers found that ketoconazole slowed disease progression by 66% in patients with glomerular disease and 77% in those with diabetic nephropathy. However, the treatment accelerated disease rate in patients with polycystic kidney disease. Further studies are needed to confirm these findings.
A study published in Neurology has identified long-term exposure to copper and manganese as a significant risk factor for developing Parkinson's disease. The study found that occupational exposure to these metals, either alone or in combination with other metals like lead and iron, increased the risk of acquiring the disease.
A recent study conducted among Native Americans has found that periodontal disease significantly increases the risk of developing heart disease in the future. The research revealed a powerful association between periodontal disease and cardiovascular disease, with diabetes being the only factor showing a stronger association.
Scientists at Purdue University have uncovered the mechanism by which disease-resistant plants recognize disease-causing microbes. The discovery reveals that a protein-protein interaction between an enzyme called Pto kinase and a protein produced by the bacterium alerts the plant's defense mechanisms, leading to effective resistance.
A new, potentially serious disease known as White Pox has been discovered on coral reefs near Key West, Florida, causing extensive damage and killing up to 80% of elkhorn coral. The cause of the disease remains unknown, but researchers are studying it to understand its origins and potential impact on the marine ecosystem.
Research by Dr. Roger Rosenberg and colleagues found that people with one-fourth Cherokee or less ancestry had a lower risk of developing Alzheimer's disease, suggesting a potential protective genetic effect. The study suggests that ancestry may play a role in delaying the development of the disease after age 65.
Recent studies from Johns Hopkins Medicine have identified genetic links to Crohn's disease, a condition affecting 400,000 US citizens. The research suggests multiple genes contribute to the disease, with earlier onset in families with a history of the condition.
A new study by the NHLBI shows that bone marrow transplantation can provide a cure for young patients with sickle cell disease who have a matched sibling. The procedure has an overall survival rate of 90% and successfully transplanted 73% of participants, free from sickle cell disease.
A rare lung disease thought to affect only people from Japan, China, and Korea has been diagnosed in five US patients with no Asian ancestry. Long-term antibiotic use can effectively treat the condition, but mortality rates remain high if left untreated.
Researchers at Duke University Medical Center found that testing for a specific gene type can accurately diagnose Alzheimer's disease in most patients. The study showed that 100% of patients with the Alzheimer's susceptibility gene had the disease's telltale neurofibrillary plaques and tangles.